Published in Circulation on August 19, 2016
The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol (1989) 37.83
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med (2002) 27.55
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med (2005) 27.36
The Cardiovascular Health Study: design and rationale. Ann Epidemiol (1991) 27.24
Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA (2001) 17.91
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA (2003) 13.79
Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA (2008) 12.28
Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med (2004) 11.46
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
Applying Cox regression to competing risks. Biometrics (1995) 6.32
Racial differences in the incidence of cardiac arrest and subsequent survival. The CPR Chicago Project. N Engl J Med (1993) 4.97
Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol (2004) 4.44
Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet (2001) 4.12
Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol (1997) 4.00
A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation (1981) 3.49
Prospective study of sudden cardiac death among women in the United States. Circulation (2003) 3.45
Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology (2009) 3.20
Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation (2010) 2.94
Clinical classification of cardiac deaths. Circulation (1982) 2.93
Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol (1985) 2.50
Serum albumin: relationship to inflammation and nutrition. Semin Dial (2005) 2.41
Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study. J Am Soc Echocardiogr (1992) 2.31
Thresholds in the relationship between mortality and left ventricular hypertrophy defined by electrocardiography. J Electrocardiol (2008) 2.29
Sudden death: lessons from subsets in population studies. J Am Coll Cardiol (1985) 2.11
Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study. Circulation (1995) 1.93
Sudden cardiac death caused by coronary heart disease. Circulation (2012) 1.73
Frequency and determinants of implantable cardioverter defibrillator deployment among primary prevention candidates with subsequent sudden cardiac arrest in the community. Circulation (2013) 1.72
Epidemiology and genetics of sudden cardiac death. Circulation (2012) 1.65
Serum albumin concentration and heart failure risk The Health, Aging, and Body Composition Study. Am Heart J (2010) 1.54
Cardiomyocyte injury assessed by a highly sensitive troponin assay and sudden cardiac death in the community: the Cardiovascular Health Study. J Am Coll Cardiol (2013) 1.53
N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study. Heart Rhythm (2010) 1.48
Out-of-hospital cardiac arrest: racial differences in outcome in Seattle. Am J Public Health (1993) 1.37
Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation (2002) 1.32
Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J (2010) 1.30
Vitamin D, parathyroid hormone, and sudden cardiac death: results from the Cardiovascular Health Study. Hypertension (2011) 1.29
Implantable defibrillators and sudden cardiac death. Circulation (2004) 1.14
Cystatin C and sudden cardiac death risk in the elderly. Circ Cardiovasc Qual Outcomes (2010) 1.14
Risk stratification for sudden cardiac death: a plan for the future. Circulation (2014) 1.14
Electrocardiographic and clinical predictors separating atherosclerotic sudden cardiac death from incident coronary heart disease. Heart (2011) 1.12
Echocardiographic left ventricular mass in African-Americans: the Jackson cohort of the Atherosclerosis Risk in Communities Study. Echocardiography (2003) 1.12
Serum albumin, coronary heart disease, and death. Am Heart J (1992) 1.03
Characteristics of sudden arrhythmic death in a diverse, urban community. Am Heart J (2012) 1.03
Inflammation and sudden cardiac death in a community-based population of older adults: the Cardiovascular Health Study. Heart Rhythm (2013) 0.94
Sudden cardiac death risk stratification. Circ Res (2015) 0.81
Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study. Am J Kidney Dis (2015) 0.79